Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $392,464 - $569,978
2,893 New
2,893 $444,000
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $120,362 - $196,415
-533 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $118,272 - $258,222
533 New
533 $205,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Heron Bay Capital Management Portfolio

Follow Heron Bay Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Heron Bay Capital Management with notifications on news.